Due to the site upgrade, your MY ACCOUNT logins will need to be updated. Please access Forgot Your Password to make this change. If you do not have an account, click here.

5-Loxin reduces knee pain and improves the ability to walk in patients with painful arthritis of the knee

Dec 12, 2008

5-Loxin is a derivative of the herb Boswellia serrata that is rich in Boswellia’s most active component known as AKBA; it is 30% AKBA. Boswellia has known anti-inflammatory activity that is due to its ability to inhibit the body’s inflammatory component known as the 5-lipoxygenase enzyme. 
In this 90 day double-blinded, randomized clinical trial, 75 patients with painful arthritis of the knee were placed on 5-Loxin or on placebo. The patients received either 100mg or 250mg of 5-Loxin or placebo per day. Each patient was individually evaluated for pain and physical function 5 times over the course of the study. At the end of the 90 day clinical trial both dosages of 5-Loxin gave clinically and statistically significant improvements in pain reduction and the ability to function. Samples of the synovial fluid show that 5-Loxin decreased the level of the MMP-3 enzyme in the joint fluid samples. The MMP-3 enzyme degrades the cartilage in the knee joint. The 5-Loxin was comparable to placebo in safety.  

5-Loxin reduced pain and improved the ability to use the knee while protecting the joint by lowering the level of the cartilage destroying enzyme MMP-3. The study is published online ahead of print in the journal Arthritis Research and Therapeutics.